New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Allergies may plague renters more than homeowners

Allergies may plague renters more than homeowners

Those who rent less likely to take steps to reduce indoor allergy triggers, study finds .(HealthDay) -- People with common indoor allergies who rent their home are much less likely than homeowners to
Immunology & Rheumatology April 08,2024
Allergies may plague renters more than homeowners

Allergies may plague renters more than homeowners

Those who rent less likely to take steps to reduce indoor allergy triggers, study finds .(HealthDay) -- People with common indoor allergies who rent their home are much less likely than homeowners to
Immunology & Rheumatology April 08,2024
Multifactorial mechanisms underlie leg weakness in hip OA

Multifactorial mechanisms underlie leg weakness in hip OA

Multiple factors contribute to leg weakness in people with hip osteoarthritis, with muscle atrophy being the strongest contributor, according to the results of a systematic review published online Jul
Immunology & Rheumatology April 08,2024
Multifactorial mechanisms underlie leg weakness in hip OA

Multifactorial mechanisms underlie leg weakness in hip OA

Multiple factors contribute to leg weakness in people with hip osteoarthritis, with muscle atrophy being the strongest contributor, according to the results of a systematic review published online Jul
Immunology & Rheumatology April 08,2024
Women with lupus seem at higher risk for hip fractures

Women with lupus seem at higher risk for hip fractures

by Kathleen Doheny, Healthday ReporterStudy followed nearly 15,000 patients for 6 years.(HealthDay)—Women with lupus—the autoimmune disease that can damage skin, joints and organs—also are at higher r
Immunology & Rheumatology April 08,2024
Women with lupus seem at higher risk for hip fractures

Women with lupus seem at higher risk for hip fractures

by Kathleen Doheny, Healthday ReporterStudy followed nearly 15,000 patients for 6 years.(HealthDay)—Women with lupus—the autoimmune disease that can damage skin, joints and organs—also are at higher r
Immunology & Rheumatology April 08,2024
ACR releases five 'Don'ts' for rheumatologists

ACR releases five 'Don'ts' for rheumatologists

As part of theChoosing Wiselycampaign, the American College of Rheumatology has issued a list of the top five tests and treatments commonly misordered by rheumatologists; the list has been
Immunology & Rheumatology April 08,2024
ACR releases five 'Don'ts' for rheumatologists

ACR releases five 'Don'ts' for rheumatologists

As part of theChoosing Wiselycampaign, the American College of Rheumatology has issued a list of the top five tests and treatments commonly misordered by rheumatologists; the list has been
Immunology & Rheumatology April 08,2024
Tofacitinib ups rheumatoid arthritis treatment response

Tofacitinib ups rheumatoid arthritis treatment response

The addition of tofacitinib to rheumatoid arthritis treatment regimens improves patient response to non-biologic disease-modifying antirheumatic drugs, according to a study published in the Aug. 20 is
Immunology & Rheumatology April 08,2024
Tofacitinib ups rheumatoid arthritis treatment response

Tofacitinib ups rheumatoid arthritis treatment response

The addition of tofacitinib to rheumatoid arthritis treatment regimens improves patient response to non-biologic disease-modifying antirheumatic drugs, according to a study published in the Aug. 20 is
Immunology & Rheumatology April 08,2024
Running won't raise risk of knee arthritis, study says

Running won't raise risk of knee arthritis, study says

In fact, it suggests running may even help prevent painful joint condition.(HealthDay)—Regular running doesn't seem to increase your chances of developing knee osteoarthritis, and it may even help
Immunology & Rheumatology April 08,2024
Running won't raise risk of knee arthritis, study says

Running won't raise risk of knee arthritis, study says

In fact, it suggests running may even help prevent painful joint condition.(HealthDay)—Regular running doesn't seem to increase your chances of developing knee osteoarthritis, and it may even help
Immunology & Rheumatology April 08,2024
Knee arthritis: Steroid shots may not help long-term, ozone injections promising

Knee arthritis: Steroid shots may not help long-term, ozone injections promising

Two studies test out old and new treatments for the debilitating ailment.(HealthDay)—Millions of aging Americans are plagued by arthritic knees, and two new studies offer insight into what might—or mi
Immunology & Rheumatology April 08,2024
Knee arthritis: Steroid shots may not help long-term, ozone injections promising

Knee arthritis: Steroid shots may not help long-term, ozone injections promising

Two studies test out old and new treatments for the debilitating ailment.(HealthDay)—Millions of aging Americans are plagued by arthritic knees, and two new studies offer insight into what might—or mi
Immunology & Rheumatology April 08,2024
Leflunomide considered safe, effective for psoriatic arthritis

Leflunomide considered safe, effective for psoriatic arthritis

Leflunomide is effective for the treatment of patients with psoriatic arthritis in daily clinical practice, according to a study published online Oct. 6 inArthritis Care & Research.(HealthDa
Immunology & Rheumatology April 08,2024
Leflunomide considered safe, effective for psoriatic arthritis

Leflunomide considered safe, effective for psoriatic arthritis

Leflunomide is effective for the treatment of patients with psoriatic arthritis in daily clinical practice, according to a study published online Oct. 6 inArthritis Care & Research.(HealthDa
Immunology & Rheumatology April 08,2024
Most expectant mothers miss out on vitamins important for their health and their baby's, study finds

Most expectant mothers miss out on vitamins important for their health and their baby's, study finds

by Keith Godfrey, Sarah El-Heis,The ConversationCredit: CC0 Public DomainOur bodies require many important vitamins and minerals in order to function well.B vitamins, for example, are part
OB & GYN April 07,2024
Most expectant mothers miss out on vitamins important for their health and their baby's, study finds

Most expectant mothers miss out on vitamins important for their health and their baby's, study finds

by Keith Godfrey, Sarah El-Heis,The ConversationCredit: CC0 Public DomainOur bodies require many important vitamins and minerals in order to function well.B vitamins, for example, are part
OB & GYN April 07,2024
Common antibiotic is a cost-saving treatment for reducing maternal sepsis, death or infection in developing countries

Common antibiotic is a cost-saving treatment for reducing maternal sepsis, death or infection in developing countries

by Society for Maternal-Fetal MedicineCredit: Pixabay/CC0 Public DomainSepsis, a severe infection that can lead to tissue damage, organ failure, and death, is one of the top three causes of mater
OB & GYN April 07,2024
Common antibiotic is a cost-saving treatment for reducing maternal sepsis, death or infection in developing countries

Common antibiotic is a cost-saving treatment for reducing maternal sepsis, death or infection in developing countries

by Society for Maternal-Fetal MedicineCredit: Pixabay/CC0 Public DomainSepsis, a severe infection that can lead to tissue damage, organ failure, and death, is one of the top three causes of mater
OB & GYN April 07,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com